Boehringer Ingelheim will perform clinical manufacturing and regulatory filing services for antibodies discovered at Elan Corp.

Elan Corp. plc

Ireland / Mid-Cap Biopharma ($1-$50 billion)

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Boehringer Ingelheim GmbH

Germany / Private Biopharma

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced